Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catumaxomab in Gastric Adenocarcinoma After Curative Resection
NCT00352833Phase 2Completed
- Sponsor
- Neovii Pharmaceuticals
- Start
- Jul 2006
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of catumaxomab in gastric adenocarcinoma, sponsored by Neovii Pharmaceuticals. Started Jul 2006; status: completed.
02
Drugs
catumaxomab
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00352833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352833.